President Donald Trump said that China's President Xi Jinping wants "to discuss the fact that they're paying 157% tariff, it's a little higher than they thought. And we're doing very well. I think we're going to do well in that negotiation."
President Donald Trump and Australian Prime Minister Anthony Albanese signed a critical minerals development framework that pledges investment in the sector, both mining and processing.
President Donald Trump confirmed to reporters on his plane on Oct. 19 that he intends to hike tariffs on Colombian goods on Oct. 21. He had earlier attacked Colombia's president on social media, calling him "an illegal drug leader," and saying that the U.S. no longer would give money to Colombia so that it can work to stop cocaine trafficking.
Peter Navarro, White House senior counselor for trade and manufacturing, argues that academics, editorial writers and analysts who say higher tariffs hurt domestic manufacturing are all wrong.
President Donald Trump, when asked if another 100% tariff on top of existing tariffs on Chinese goods would damage the economy, said, "It's not sustainable, but that's what the number is."
President Donald Trump posted on social media that he and Russian President Vladimir Putin had a long, "very productive" phone call on Oct. 16. In addition to talking about the ceasefire in Gaza and the first lady's efforts to get Ukrainian children held in Russia or Russia-occupied Ukraine back to their parents in free Ukraine, "we also spent a great deal of time talking about Trade between Russia and the United States when the War with Ukraine is over," he wrote.
President Donald Trump, in response to a question about whether he would engage in trade talks with India, said that Indian Prime Minister Narendra Modi "assured me today that they will not be buying oil from Russia. That's a big stop. Now I got to get China to do the same thing."
White House National Economic Council Director Kevin Hassett told an Axios interviewer that the administration was taken aback by China's announcement of extraterritorial export controls on products made with rare earths processed in China.
Pharmaceutical company AstraZeneca reached a deal with the Trump administration that will delay Section 232 tariffs for three years, the company announced in an Oct. 10 press statement.
A White House official said that active pharmaceutical ingredients imported into the U.S. for medicine manufacturing will be covered by the Section 232 tariffs on branded pharmaceuticals.